Ticker Details
Relay Therapeutics, Inc.
IPO Date:	July 16, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.51B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.61 | 3.35%
Avg Daily Range (30 D):	$0.26 | 3.19%
Avg Daily Range (90 D):	$0.23 | 3.10%

Institutional Daily Volume
Avg Daily Volume:	1.03M
Avg Daily Volume (30 D):	1.83M
Avg Daily Volume (90 D):	1.82M

Trade Size
Avg Trade Size (Sh.):	94
Avg Trade Size (Sh.) (30 D):	92
Avg Trade Size (Sh.) (90 D):	97

Institutional Trades
Total Institutional Trades:	2,562
Avg Institutional Trade:	$2.22M
Avg Institutional Trade (30 D):	$1.88M
Avg Institutional Trade (90 D):	$1.91M
Avg Institutional Trade Volume:	.16M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.77M
Avg Closing Trade (30 D):	$2.47M
Avg Closing Trade (90 D):	$2.17M
Avg Closing Volume:	201.81K

News

Feb 23, 2026 @ 3:18 PM Spyre Therapeutics Stock Surges This Past Year as ... Source: Jonathan Ponciano

Feb 23, 2026 @ 3:01 PM Biotech Fund Dumps $84 Million of Nuvalent With St... Source: Jonathan Ponciano

Feb 19, 2026 @ 10:55 PM Relay Therapeutics to Announce Fourth Quarter and ... Source: Na

Feb 5, 2026 @ 2:35 PM $207B Market Shift: The Race for Fast Track Approv... Source: Prnewswire

Dec 12, 2025 @ 12:00 PM Relay Therapeutics Announces Efficacy Subset Analy... Source: Relay Therapeutics

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.43	$-.41	$-.46
Diluted EPS	$-.43	$-.41	$-.46
Revenue	$M	$.68M	$7.68M
Gross Profit
Net Income / Loss	$-74.15M	$-70.38M	$-77.07M
Operating Income / Loss	$-80.39M	$-76.85M	$-84.87M
Cost of Revenue
Net Cash Flow	$-22.38M	$-10.21M	$M
PE Ratio